Search results
A combination vaccine for flu and COVID-19 is in the works. Here's what to know.
USA TODAY via Yahoo News· 2 years agoAs the holiday season draws near, more Americans may be sporting two Band-Aids after receiving both...
Will Americans have the right COVID-19 vaccine this fall? Maybe
LA Times via Yahoo News· 2 years agoA man walks underneath the marquee of the Alex Theatre in Glendale. The Food and Drug Administration...
Nasal COVID-19 vaccines help the body prepare for infection right where it starts – in your nose and...
The Conversation via Yahoo News· 2 years agoSeven nasal vaccines for COVID-19 are currently in clinical trials around the world. VSargues/iStock...
Feds could soon approve COVID vaccine for kids under 5. What to know in NY
Lohud | The Journal News via Yahoo News· 2 years agoThe push to vaccinate the youngest New Yorkers against COVID-19 is poised to begin next week, as...
Another COVID-19 wave is expected to hit Oregon this month. Here's where to get vaccines, boosters
Statesman Journal via Yahoo News· 2 years agoOregon is heading into another surge of coronavirus infections, with cases expected to begin...
Moderna Stock: Bear vs. Bull
Motley Fool· 1 year agoInvestors have gotten used to Moderna (NASDAQ: MRNA) delivering earnings growth. Thanks to its coronavirus vaccine, the biotech has reported billions of...
If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today
Motley Fool· 1 year agoModerna's (NASDAQ: MRNA) success in the coronavirus vaccine race has equaled success for early...
Should You Worry About the Latest Wave of Bad News from Pfizer?
Motley Fool via Yahoo Finance· 5 months agoEarlier in the pandemic, Pfizer (NYSE: PFE) stood out as an earnings and stock-market star thanks to...
Is the COVID surge over in Florida? How deadly has this summer been? Should I get the vaccine?
Palm Beach Daily News via Yahoo News· 8 months agoIs COVID-19 surging in Florida? It was, and it seems to be slowing down. Every summer and into the...
Is Moderna a Bad-News Buy?
Motley Fool· 2 years agoThe coronavirus vaccine maker posted a 35% drop in third-quarter product sales. The company also recorded a charge for inventory write-downs, linked to...
